THIADIAZOLIDINEDIONES AS GSK-3 INHIBITORS

The present invention relates to new thiadiazolidmediones of formula (I), or any pharmaceutically acceptable salt, solvate or prodrug thereof, and its use in the treatment of a disease in which glycogen synthase kinase 3 (GSK-3) is involved, particularly neurodegenerative diseases, inflammatory and...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	DOMINGUEZ CORREA, JUAN MANUEL, PALOMO NICOLAU, FRANCISCO, DE CRISTOBAL BLANCO, JAVIER, LOPEZ OGALLA, JAVIER, HERRERO SANTOS, SUSANA, MARTINEZ MONTERO, OLGA, RODRIGUEZ SALGUERO, BEATRIZ, SANCHEZ-QUESADA, JORGE, MEDINA PADILLA, MIGUEL, PEREZ DE LA CRUZ MORENO, MARIA ANGELES, FUERTES HUERTA, ANA
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to new thiadiazolidmediones of formula (I), or any pharmaceutically acceptable salt, solvate or prodrug thereof, and its use in the treatment of a disease in which glycogen synthase kinase 3 (GSK-3) is involved, particularly neurodegenerative diseases, inflammatory and autoimmune diseases and cardiovascular disorders. Additionally, there is provided a process for preparing such compounds, as well as pharmaceutical compositions comprising them. La présente invention concerne de nouvelles thiadiazolidine-diones de formule (I), ou tout sel, solvate ou promédicament de celles-ci pharmaceutiquement acceptable, et leur utilisation dans le traitement d'une maladie dans laquelle la glycogène synthase kinase-3 (GSK -3) est impliquée, en particulier, les maladies neurodégénératives, les maladies inflammatoires et auto-immunes et les troubles cardio-vasculaires. En outre, l'invention concerne un procédé de préparation de ces composés, ainsi que des compositions pharmaceutiques les comprenant.